Brief: Synlogic Says It Is On Track To Initiate Phase 3 For PKU Treatment In H2

Synlogic

06/01/2022 12:21

Jan 6 (Reuters) - Synlogic Inc  SYBX.O :
    * SYNLOGIC ANNOUNCES PROGRESS TOWARD 2022 CLINICAL
MILESTONES AND
PARTICIPATION AT UPCOMING INVESTOR CONFERENCES
    * SYNLOGIC INC - ON TRACK TO INITIATE PHASE 3 FOR TREATMENT
OF
PHENYLKETONURIA (PKU) IN H2 2022
    * SYNLOGIC - ADDITIONAL MILESTONES INCLUDE MULTIPLE CLINICAL
READ-OUTS ACROSS PROGRAMS INCLUDING ENTERIC HYPEROXALURIA &
HOMOCYSTINURIA (HCU) DURING 2022

Source text for Eikon:  ID:nGNX6s6ZMJ 
Further company coverage:  SYBX.O 

 ((Reuters.Briefs@thomsonreuters.com;))